Tema Cardiovascular and Metabolic ETF Rating → How to Play the AI and Crypto Markets in One Swing (From Weiss Ratings) (Ad) Free HRTS Stock Alerts $32.81 +0.62 (+1.93%) (As of 05/15/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Tema Cardiovascular and Metabolic ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy2.75Holdings in HRTS have an aggregate rating of Moderate Buy based on 421 analyst ratings issued in the past year covering 40 companies (86.6% of the portfolio).HRTS Aggregate Price Target$48.2747.12% UpsideHigh Prediction$65.09Average Prediction$48.27Low Prediction$32.67Holdings in HRTS have an aggregate price target of $48.27 and a range of $32.67 to $65.09 covering 40 companies (86.6% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolic ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 HRTS Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.39%VRTXVertex Pharmaceuticals$437.49+2.1%4 of 5 stars2.48$432.18 -1.2%255.34%AMGNAmgen$319.04+2.5%5 of 5 stars2.52$305.65 -4.2%21Options Volume4.96%LLYEli Lilly and Company$787.24+3.0%5 of 5 stars2.84$769.53 -2.3%19Analyst ForecastShort Interest ↓4.25%DXCMDexCom$129.71+3.0%5 of 5 stars2.93$141.67 9.2%14Short Interest ↓Positive News3.07%PODDInsulet$180.56+4.8%5 of 5 stars2.82$239.44 32.6%17Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.96%CRNXCrinetics Pharmaceuticals$50.49+2.2%4 of 5 stars2.92$58.42 15.7%12Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓News Coverage2.86%CYTKCytokinetics$60.50+1.9%4 of 5 stars2.87$81.60 34.9%15Earnings ReportAnalyst ForecastAnalyst Revision2.83%MDTMedtronic$84.72+0.5%5 of 5 stars2.40$94.91 12.0%102.80%EWEdwards Lifesciences$90.16+4.3%5 of 5 stars2.58$93.88 4.1%19Analyst UpgradeInsider SellingShort Interest ↑2.79%ALNYAlnylam Pharmaceuticals$147.40-0.3%4 of 5 stars2.59$216.19 46.7%17Short Interest ↑2.68%BBIOBridgeBio Pharma$29.97+3.5%5 of 5 stars2.82$48.00 60.2%11Analyst ForecastShort Interest ↑News CoverageGap Up2.62%NARIInari Medical$46.99+3.3%3 of 5 stars2.71$65.71 39.8%7Insider SellingNews Coverage2.62%BSXBoston Scientific$74.45+1.3%4 of 5 stars2.95$75.09 0.9%21Analyst ForecastInsider SellingShort Interest ↑2.60%ASNDAscendis Pharma A/S$124.04-0.6%1 of 5 stars2.88$173.88 40.2%8Analyst ForecastNews CoverageHigh Trading Volume2.52%RCKTRocket Pharmaceuticals$23.66+1.2%5 of 5 stars2.89$52.13 120.3%9Gap Up2.43%MREOMereo BioPharma Group$3.17+7.1%2 of 5 stars3.00$6.50 105.0%2News CoveragePositive News2.33%NTLAIntellia Therapeutics$26.22+1.9%4 of 5 stars2.69$66.77 154.7%13Gap Up2.30%VKTXViking Therapeutics$78.01+7.6%5 of 5 stars3.00$112.25 43.9%10Gap Up2.29%RAREUltragenyx Pharmaceutical$41.12+0.4%4 of 5 stars2.92$87.85 113.6%122.25%WSTWest Pharmaceutical Services$351.46-0.9%5 of 5 stars2.80$435.20 23.8%52.11%BMYBristol-Myers Squibb$44.55-0.4%5 of 5 stars2.11$60.00 34.7%19Short Interest ↓Analyst Revision2.08%IONSIonis Pharmaceuticals$39.21+2.5%4 of 5 stars2.71$59.54 51.8%14Short Interest ↓2.05%MASIMasimo$116.15+0.8%5 of 5 stars2.43$138.71 19.4%71.75%KROSKeros Therapeutics$54.40+3.0%3 of 5 stars3.00$86.00 58.1%7Earnings ReportAnalyst RevisionGap Up1.72%MLYSMineralys Therapeutics$13.07+0.1%2 of 5 stars3.00$33.50 156.3%3Gap Up1.60%OMCLOmnicell$29.87-1.4%2 of 5 stars2.33$42.20 41.3%6Positive News1.48%ARWRArrowhead Pharmaceuticals$25.04+9.3%4 of 5 stars2.78$51.00 103.7%9Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageGap Up1.45%MIRMMirum Pharmaceuticals$24.99+0.8%5 of 5 stars3.10$49.73 99.0%10Analyst RevisionGap Up1.36%MDGLMadrigal Pharmaceuticals$211.73+0.4%4 of 5 stars2.73$345.09 63.0%11Analyst RevisionGap Up1.36%OSCROscar Health$22.65-0.8%2 of 5 stars2.67$15.00 -33.8%61.25%SWAVShockwave Medical$330.870.0%4 of 5 stars2.09$309.11 -6.6%11Positive News1.19%AKROAkero Therapeutics$21.07+3.8%4 of 5 stars2.88$41.13 95.2%8Upcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.08%ARCTArcturus Therapeutics$29.02-2.4%2 of 5 stars3.00$64.86 123.5%7Short Interest ↑0.98%TNYATenaya Therapeutics$4.25-3.4%2 of 5 stars3.00$15.40 262.4%7Analyst ForecastNews Coverage0.82%SLNOSoleno Therapeutics$45.21+3.9%4 of 5 stars3.14$60.33 33.5%7Analyst ForecastGap Up0.71%SLNSilence Therapeutics$22.33+5.6%3 of 5 stars3.00$57.25 156.4%4Upcoming Earnings0.67%GPCRStructure Therapeutics$36.07+1.0%2 of 5 stars3.00$85.71 137.6%6News Coverage0.43%VERVVerve Therapeutics$6.233 of 5 stars2.75$33.00 429.7%8Earnings ReportInsider BuyingAnalyst RevisionGap Up0.31%SKYESkye Bioscience$12.68+4.4%1 of 5 stars3.00$22.50 77.4%2Earnings Report0.31%SKYESkye Bioscience$12.68+4.4%1 of 5 stars3.00$22.50 77.4%2Earnings Report This page (NYSEARCA:HRTS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
